Novo Nordisk Obesity Drug Wins FDA Panel Support

An FDA advisory panel recently recommended the approval of Novo Nordisk's injectable drug liraglutide for the treatment of obesity. Read the rest of the story... »
Source: Highlight HEALTH - Category: Medical Scientists Authors: Source Type: blogs